PNC Financial Services Group’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
Other funds holding GMAB
DGM
PNC Financial Services Group's GMAB Position: Q3 2026 in Review
PNC Financial Services Group increased its Genmab (GMAB) stake by 6% in Q3 2026, buying an estimated $41K and bringing the position to 23,017 shares worth $821K. The position accounts for ﹤0.01% of the portfolio, ranked #1442.
PNC Financial Services Group first reported a position in GMAB in Q3 2019 and has held it in 29 quarters since. The position peaked at $8.52M in Q3 2021. 333 funds tracked by Wall St. Rank hold GMAB as of Q3 2026.
- PNC Financial Services Group held 23,017 shares of Genmab worth $821K as of Q3 2026.
- PNC Financial Services Group bought 1,296 Genmab shares in Q3 2026, an estimated $41K.
- Genmab made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #1442 holding.
- PNC Financial Services Group first reported a position in Genmab in Q3 2019 and has held it in 29 quarters since.
- PNC Financial Services Group's Genmab position peaked at $8.52M in Q3 2021.
- 333 funds tracked by Wall St. Rank held Genmab as of Q3 2026.
Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.